SMARCB1 and rhabdoid tumor: These cell lines, derived from rhabdoid tumors of different origin (brain, BT12 and BT16; kidney, G401; and liver, TTC549), were modified to conditionally express SMARCB1 in the presence of doxycycline (14, 21).